Scholarlink

Objectives <p>To describe the hospitalization spending for cancers in Hunan Province, China, and to investigate the hospitalization cost across diverse cancer classifications.</p> Methods <p>We conducted a retrospective study based on the hospitalization admission data from 2017 to 2019 in Hunan Province. We retrieved information on age, sex, diagnosis, number of comorbidities, level of hospitalization, hospital location, hospital costs, length of stay, and type of payer for eligible participants. Factors for cost (log-transformed) were investigated through multiple linear regression.</p> Results <p>A total of 872,309 records of cancer were hospitalized in Hunan Province during 2017–2019, with a total cost of US$2490.36 million, and 64.10% of the cost was covered by medical insurance. The top five cancers in terms of cost were lung (300.32 million), colorectum ($234.56 million), liver ($126.46 million), lip, oral cavity &amp; pharynx ($102.29 million), and stomach ($98.98 million) cancers in men, were breast ($176.03 million), colorectum ($156.15 million), cervix ($112.68 million), lung ($112.21 million), and thyroid ($56.75 million) cancers in women, respectively. Site of cancer, sex, age, year of hospitalization, number of comorbidities, length of stay, hospital level, and hospital location were significantly associated with the per-capita log-transformed cost.</p> Conclusion <p>The economic burden of cancer was heavy in Hunan, and lung, colorectal, breast, liver, and stomach cancers accounted for half of the total cost. Site of cancer, sex, age, comorbidity, level, and location of hospital were factors for the per-capita cost.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hospital spending for cancers in Hunan, China during 2017 and 2019

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月8日

查看全文
  • Mengyao Xu,
  • Mengjiao Liu,
  • Liqiu Liao,
  • Minxue Shen

摘要

Objectives

To describe the hospitalization spending for cancers in Hunan Province, China, and to investigate the hospitalization cost across diverse cancer classifications.

Methods

We conducted a retrospective study based on the hospitalization admission data from 2017 to 2019 in Hunan Province. We retrieved information on age, sex, diagnosis, number of comorbidities, level of hospitalization, hospital location, hospital costs, length of stay, and type of payer for eligible participants. Factors for cost (log-transformed) were investigated through multiple linear regression.

Results

A total of 872,309 records of cancer were hospitalized in Hunan Province during 2017–2019, with a total cost of US$2490.36 million, and 64.10% of the cost was covered by medical insurance. The top five cancers in terms of cost were lung (300.32 million), colorectum ($234.56 million), liver ($126.46 million), lip, oral cavity & pharynx ($102.29 million), and stomach ($98.98 million) cancers in men, were breast ($176.03 million), colorectum ($156.15 million), cervix ($112.68 million), lung ($112.21 million), and thyroid ($56.75 million) cancers in women, respectively. Site of cancer, sex, age, year of hospitalization, number of comorbidities, length of stay, hospital level, and hospital location were significantly associated with the per-capita log-transformed cost.

Conclusion

The economic burden of cancer was heavy in Hunan, and lung, colorectal, breast, liver, and stomach cancers accounted for half of the total cost. Site of cancer, sex, age, comorbidity, level, and location of hospital were factors for the per-capita cost.